Contact
searchSearch
HMP Global

News

cream
News
Behenic Acid and Ceramide Creams Accelerate Skin Barrier Recovery
10/13/2026
Coleen Stern, MA
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid...
10/13/2026
The Dermatologist
News
Pediatric Psoriasis Review Highlights Diagnostic Challenges, Expanding Role of Biologics
10/07/2026
Jessica Garlewicz
Pediatric psoriasis can substantially affect quality of life and contribute to cumulative life course impairment, but evidence guiding its management remains limited compared with adult disease.
Pediatric psoriasis can substantially affect quality of life and contribute to cumulative life course impairment, but evidence guiding its management remains limited compared with adult disease.
Pediatric psoriasis can...
10/07/2026
The Dermatologist
News
Psoriasis Reframed as Systemic Disease With Metabolic and Hepatic Implications
10/07/2026
Jessica Garlewicz
Psoriasis should be recognized as a systemic inflammatory disease requiring management beyond cutaneous symptoms.
Psoriasis should be recognized as a systemic inflammatory disease requiring management beyond cutaneous symptoms.
Psoriasis should be recognized...
10/07/2026
The Dermatologist
News
GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Risk in Patients With Psoriasis
10/07/2026
Jessica Garlewicz
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor...
10/07/2026
The Dermatologist
News
Microbial Dysbiosis May Shape Psoriasis Pathogenesis Through the Gut-Skin Axis
10/07/2026
Jessica Garlewicz
A review suggests microbial dysbiosis may link genetic, immune, and environmental factors in psoriasis, with implications for personalized treatment.
A review suggests microbial dysbiosis may link genetic, immune, and environmental factors in psoriasis, with implications for personalized treatment.
A review suggests microbial...
10/07/2026
The Dermatologist
Smiling woman touching neck
News
Anatomy-Driven Model Aims to Prevent GLP-1 RA–Associated Facial Aging
10/01/2026
Coleen Stern, MA
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an...
10/01/2026
The Dermatologist
dkin
News
Review Reframes Skin Barrier as an Integrated Defense System
09/30/2026
Coleen Stern, MA
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an...
09/30/2026
The Dermatologist
News
Poor Cardiovascular-Kidney-Metabolic Health Linked to Psoriasis Risk, Reduced Life Expectancy
09/03/2026
Jessica Garlewicz
Poor cardiovascular-kidney-metabolic health was associated with an increased risk of developing psoriasis.
Poor cardiovascular-kidney-metabolic health was associated with an increased risk of developing psoriasis.
Poor...
09/03/2026
The Dermatologist
News
Routine Latent TB Testing Not Required With IL-17, IL-23 Inhibitors, Experts Say
09/03/2026
Jessica Garlewicz
Testing for latent tuberculosis infection has been standard practice among patients with psoriasis treated with IL-17 or IL-23 inhibitors. However, the experts noted that evidence supporting routine testing in these patients is weak.
Testing for latent tuberculosis infection has been standard practice among patients with psoriasis treated with IL-17 or IL-23 inhibitors. However, the experts noted that evidence supporting routine testing in these patients is weak.
Testing for latent tuberculosis...
09/03/2026
The Dermatologist
News
Lipidomics May Help Identify Biomarkers of Psoriasis Activity and Treatment Response
09/03/2026
Jessica Garlewicz
The review focused on identifying and characterizing lipid profile alterations in psoriasis and evaluating pro-inflammatory lipids as potential biomarkers of disease activity and treatment response.
The review focused on identifying and characterizing lipid profile alterations in psoriasis and evaluating pro-inflammatory lipids as potential biomarkers of disease activity and treatment response.
The review focused on...
09/03/2026
The Dermatologist

Popular Articles

psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
Jessica Garlewicz
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
Riya Gandhi, MA
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
illustration of serum drop on skin cell
Microneedling Immunosuppressants for Alopecia Areata Hair Regrowth
11/04/2024
Alopecia areata (AA) is an autoimmune disease affecting approximately 160 million people worldwide.1 With AA, the immune system attacks hair follicles, resulting in hair loss and preventing hair regrowth.2 The standard approach to treating...
Alopecia areata (AA) is an autoimmune disease affecting approximately 160 million people worldwide.1 With AA, the immune system attacks hair follicles, resulting in hair loss and preventing hair regrowth.2 The standard approach to treating...
Alopecia areata (AA) is an...
11/04/2024
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes and Trivia

AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use